Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
New Haven Pharmaceuticals
>
Dulaza Sold - Good Luck!
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5826104"]THE WOODLANDS, Texas, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:<a href="https://globenewswire.com/News/Listing?symbol=RPRX&exchange=2" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://globenewswire.com/News/Listing?symbol=RPRX&exchange=2" rel="nofollow">RPRX</a>) today announced that Joseph S. Podolski is leaving his position as President and Chief Executive Officer and member of the Board of Directors to pursue other interests. <b>Larry Dillaha</b>, M.D., Chief Executive Officer of CavtheRx, was appointed interim President and Chief Executive Officer of the Company, effective immediately.</p><p><br /></p><p>“As Repros continues to advance its pipeline, the board will be conducting a search for a CEO with the appropriate experience to lead the Company’s next stage of growth,” said <b>Patrick Fourteau</b>, Chairman of the Company’s Board. “We’re grateful for Joe’s many years of dedication to Repros and wish him every success in his future endeavors.”</p><p><br /></p><p>Prior to becoming CEO of CavtheRx, Dr. Dillaha was Chief Operating Officer and Chief Medical Officer of <b>New Haven Pharmaceuticals,</b> a specialty pharmaceutical company. He also served as Chief Medical Officer of Insys Therapeutics, Sciele Pharma and as Medical Director of Sanofi-Sythelabo. Dr. Dillaha received an M.D. degree from the University of Tennessee, Memphis.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5826104"]THE WOODLANDS, Texas, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:[URL='https://globenewswire.com/News/Listing?symbol=RPRX&exchange=2']RPRX[/URL]) today announced that Joseph S. Podolski is leaving his position as President and Chief Executive Officer and member of the Board of Directors to pursue other interests. [B]Larry Dillaha[/B], M.D., Chief Executive Officer of CavtheRx, was appointed interim President and Chief Executive Officer of the Company, effective immediately. “As Repros continues to advance its pipeline, the board will be conducting a search for a CEO with the appropriate experience to lead the Company’s next stage of growth,” said [B]Patrick Fourteau[/B], Chairman of the Company’s Board. “We’re grateful for Joe’s many years of dedication to Repros and wish him every success in his future endeavors.” Prior to becoming CEO of CavtheRx, Dr. Dillaha was Chief Operating Officer and Chief Medical Officer of [B]New Haven Pharmaceuticals,[/B] a specialty pharmaceutical company. He also served as Chief Medical Officer of Insys Therapeutics, Sciele Pharma and as Medical Director of Sanofi-Sythelabo. Dr. Dillaha received an M.D. degree from the University of Tennessee, Memphis.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
New Haven Pharmaceuticals
>
Dulaza Sold - Good Luck!
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
New Haven Pharmaceuticals
>
Dulaza Sold - Good Luck!
>